Jubilant Life Sciences
Jubilant Life Sciences, a prominent player in the pharmaceutical and life sciences sector, is headquartered in Noida, India. Founded in 1978, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in contract manufacturing, active pharmaceutical ingredients (APIs), and drug delivery solutions, Jubilant Life Sciences is recognised for its commitment to quality and innovation.
The company’s core offerings, which include a diverse range of generic pharmaceuticals and specialty chemicals, set it apart in a competitive market. With a focus on sustainability and advanced technology, Jubilant Life Sciences has achieved significant milestones, including multiple regulatory approvals and partnerships with leading global firms. This positions the company as a trusted partner in the healthcare industry, dedicated to improving patient outcomes worldwide.
+5 vs industry average
Jubilant Life Sciences’s score of 43 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Jubilant Life Sciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Jubilant Life Sciences's reported carbon emissions
In 2025, Jubilant Life Sciences reported total carbon emissions of approximately 634,000,000 kg CO2e, comprising 10,084,000 kg CO2e from Scope 1, 64,219,000 kg CO2e from Scope 2, and 527,407,000 kg CO2e from Scope 3 emissions. This data reflects a comprehensive approach to emissions reporting, including all relevant scopes. The company has set ambitious climate commitments, aiming for net zero emissions by 2050 for both Scope 1 and Scope 2 emissions, with a target start year of 2023. This long-term goal demonstrates a commitment to sustainability and aligns with global climate initiatives. Jubilant Life Sciences' emissions data is not cascaded from any parent organization, ensuring that their reported figures are independently sourced. The company actively engages in reducing its carbon footprint, reflecting a proactive stance in addressing climate change within the life sciences sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Jubilant Life Sciences’s Climate Goals (2030 & 2050)
2 goals2050
We aim to achieve net zero emissions by 2050
We aim to achieve net zero emissions by 2050.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project